The future of immunotherapy looks promising, with ongoing research focused on improving existing treatments and developing new strategies. Areas of interest include combination therapies, personalized vaccines, and the use of biomarkers to predict patient response. Advances in understanding the tumor microenvironment and immune system interactions hold the potential to significantly improve outcomes for cancer patients.
